Industry News
Medical Device Industry News

Labcorp Receives FDA De Novo Marketing Authorization for PGDx elio plasma focus Dx
"The launch of PGDx elio plasma focus Dx represents a landmark expansion of Labcorp's suite of precision oncology solutions," said Shakti Ramkissoon, M.D., Ph.D., MBA, vice president, medical lead for oncology at Labcorp. "This latest
Sensitech Completes Acquisition of Berlinger & Co. Monitoring Solutions Expanding Life Sciences Cold Chain Solutions
"This successful acquisition marks a strategic milestone for Sensitech, creating comprehensive and differentiated cold chain monitoring and visibility solutions for the pharma and life sciences industry," said Bhasker Kaushal, Vice President & General Manager, Sensitech
FDA Approves First Gene Therapy to Treat Adults with Metastatic Synovial Sarcoma
"Potentially life-threatening cancers such as synovial sarcoma continue to have a devastating impact on individuals, especially those for whom standard treatments have limited efficacy due to tumor growth and progression," said Peter Marks, M.D., Ph.D.,
José Trevejo M.D. Ph.D Appointed Chief Medical Office at Enveda Biosciences
Dr. José Trevejo joins Enveda following a string of recent successes, most recently at Tarsus Pharmaceuticals, where he helped lead the FDA approval and launch of a novel category-creating ophthalmic treatment along with multiple positive
MilliporeSigma Announces Closing of Mirus Bio Acquisition, Bolstering Viral Vector Bioproc
The acquisition is a strategic step towards the company’s ambition to offer solutions for every step of viral vector manufacturing. It also reinforces the company’s commitment to supporting customers in advancing cell and gene therapies
Nexus Children’s Hospital – Dallas Partners with Pediatric Acute Care Associates to Improve Continuity of Care
"We are thrilled to partner with Dr. Papo and Pediatric Acute Care Associates of North Texas to provide a more seamless transition from intensive to transitional care," said Nexus Children's Hospital – Dallas CEO Roger
Rejuvenate Biomed and SAS Tap AI to Develop Disease-agnostic Drug Repurposing Discovery Tools
"Our partnership with SAS amplifies the core strengths of both our R&D teams," Dr. Ann Beliën, Founder and Chief Executive Officer of Rejuvenate Biomed. "By embracing this partnership and leveraging the capabilities of SAS Viya,
SURGLASSES Announces Successful First Clinical Implementation of Caduceus S AR Surgical Navigation System in Thailand
Dr. Chaiyos Chaichankul remarked, "The AR technology of the Caduceus S surgical navigation system allows us to precisely locate and treat the affected area, greatly increasing the success rate of surgeries and accelerating patient recovery."
Top 4 Tips for Working Out While Pregnant
When those two lines first pop up on the pregnancy test, it’s a moment in your life you’ll never forget. What follows is a lot of planning, preparation, and questions— What comes next? What will
Stryker’s Spine Guidance 5 Software featuring Copilot receives 510(k) clearance from FDA
Q Guidance System with Spine Guidance 5 Software featuring Copilot is a first-to-market technology, pioneering new planning and surgical capabilities.
Atraverse Medical Announces First Clinical Use of HOTWIRE™ Radiofrequency (RF) Guidewire System at St. Bernards Medical Center
Eric Sauter, COO and Co-Founder for Atraverse Medical, commented, "Our mission is to improve efficiency and take the guesswork out of what should be simply-executed therapeutic and diagnostic procedures. Our collaboration with Dr. Nair exemplifies
Silk Road Medical Celebrates Milestone of 100,000 Transcarotid Artery Revascularization (TCAR) Procedures
Studied across thousands of patients and supported by hundreds of clinical publications, the TCAR pioneer has continually delivered positive outcomes through minimally invasive techniques.
Alexandrite Lasers vs. IPL: Which Is Better for Your Practice
Let's dive into what makes each technology tick, and how choosing the right used aesthetic laser or IPL system could make all the difference in how your practice performs. Ready to figure out which one
Who Makes Nitrile Gloves in the United States?
For years, the global supply chain dominated the nitrile glove market. However, recent events, including the COVID-19 pandemic, have underscored the critical need for domestic manufacturing to ensure a stable and reliable supply. In this
RetiSpec Closes $10M USD to Advance Commercialization of its AI-Driven Eye Test for Detection of Alzheimer’s Disease
This funding will enable RetiSpec to accelerate the commercialization of its groundbreaking technology aimed at early detection of Alzheimer's disease.
Vascular Surgery
Vascular surgery is a branch of medicine that deals with the diagnosis and treatment of diseases affecting the blood vessels. It has a significant historical relevance, with advancements and milestones that have shaped the field
Providence St Joseph Hospital Performs World’s First Spine Surgery Using eCential Robotics’ Open Spine Robot, with Spineart Compatible Implants
“In our relentless pursuit of innovation and excellence in patient care, we were eager to utilize the solutions provided by Spineart and eCential,” said Erick Westbroek*, M.D., Providence St Joseph spinal surgeon. “The integration of
New Studies Validate the Value of Brainomix AI Technology Across US Stroke Networks
The latest research, in collaboration with the Mayo Clinic, West Virginia University, and Boston Medical Center, highlighted some of the cutting-edge, AI-enabled technology that the Oxford-based company has developed within its pipeline for the Brainomix
Delray Medical Center | 1st Hospital in Florida to Use Innovative Treatment for Abdominal Aortic Aneurysm
“We are proud that Dr. Ricotta, a highly respected member of the Delray Medical Center Medical Staff, was selected to participate in this important clinical trial and we congratulate him on being the first surgeon
Teva Pharmaceuticals and Sanofi Announce Accelerated Timeline for Anti-TL1A Phase 2b Program in Patients with Inflammatory Bowel Disease
Patient enrollment in the RELIEVE UCCD (ulcerative colitis and Crohn’s disease) Phase 2b trial has completed early due to significant acceleration in patient recruitment. As a result, Teva Pharmaceuticals and Sanofi now anticipate having topline



